Editas Medicine (EDIT) Total Current Liabilities (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Total Current Liabilities data on file, last reported at $46.2 million in Q4 2025.

• Total Current Liabilities for Q4 2025 came in at $46.2 million, down 40.12% year-over-year; the trailing twelve-month figure through Dec 2025 was $46.2 million (down 40.12% YoY), and the FY2025 annual result was $46.2 million, down 40.12% from the prior year.
• Total Current Liabilities eased to $46.2 million in Q4 2025 per EDIT's latest filing, from $61.8 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $77.2 million in Q4 2024 and troughed at $36.4 million in Q2 2022.
• A 5-year average of $58.7 million and a median of $60.9 million in 2022 frame the typical range for Total Current Liabilities.
• The sharpest annual moves came in 2022 and 2023: Total Current Liabilities sank 44.83% in 2022, then surged 56.58% in 2023.
• A 5-year view of Total Current Liabilities shows it stood at $46.9 million in 2021, then rose by 28.21% to $60.1 million in 2022, then advanced by 5.17% to $63.2 million in 2023, then climbed by 22.16% to $77.2 million in 2024, then sank by 40.12% to $46.2 million in 2025.
• Business Quant data shows EDIT's Total Current Liabilities at $46.2 million in Q4 2025, $61.8 million in Q3 2025, and $65.9 million in Q2 2025.